TickerFacts.

Alkermes plc. (ALKS): Gross Profit

Revenue minus cost of revenue for the same annual period and currency, computed by TickerFacts from the filed figures. The issuer may report gross profit or margin on a different basis.

Computed by TickerFacts from revenue minus cost of revenue. This may differ from the issuer's reported gross profit or margin; check the revenue and cost definitions.

$1.28B
Year ended 2025-12-31
$1.41B
Trailing 12 months to 2026-06-30
+12.7%
3-year compound annual growth
+8.3%
5-year compound annual growth
+10.1%
10-year compound annual growth
$1.41B2010-03-31: $128.84M2011-03-31: $134.46M2012-03-31: $262.40M2014-12-31: $442.96M2015-12-31: $489.35M2016-12-31: $613.57M2017-12-31: $748.63M2018-12-31: $917.85M2019-12-31: $990.56M2020-12-31: $860.44M2021-12-31: $976.43M2022-12-31: $893.73M2023-12-31: $1.41B2024-12-31: $1.31B2025-12-31: $1.28B$1.28B
2010-03-31 Gross Profit (USD) 2025-12-31
Period endedGross ProfitChange YoYSource filing
2025-12-31$1.28B-2.5%2026-02-25, From 2025-01-01
2024-12-31$1.31B-7.0%2026-02-25, From 2024-01-01
2023-12-31$1.41B+57.8%2026-02-25, From 2023-01-01
2022-12-31$893.73M-8.5%2025-02-12, From 2022-01-01
2021-12-31$976.43M+13.5%2024-02-21, From 2021-01-01
2020-12-31$860.44M-13.1%2023-02-16, From 2020-01-01
2019-12-31$990.56M+7.9%2022-02-16, From 2019-01-01
2018-12-31$917.85M+22.6%2021-02-11, From 2018-01-01
2017-12-31$748.63M+22.0%2020-02-13, From 2017-01-01
2016-12-31$613.57M+25.4%2019-02-15, From 2016-01-01
2015-12-31$489.35M+10.5%2018-02-16, From 2015-01-01
2014-12-31$442.96Mn/a2017-02-17, From 2014-01-01
No annual figure between 2012-03-31 and 2014-12-31.
2012-03-31$262.40M+95.2%2013-05-23, From 2011-04-01
2011-03-31$134.46M+4.4%2013-05-23, From 2010-04-01
2010-03-31$128.84Mn/a2012-05-18, From 2009-04-01

Gross Profit at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedGross ProfitChange YoY
Alkermes plc. (ALKS)2025-12-31$1.28B-2.5%
Phibro Animal Health Corp (PAHC)2026-06-30$512.51M+28.1%
Indivior Pharmaceuticals, Inc. (INDV)2025-12-31$994.00M+3.9%
Prestige Consumer Healthcare Inc. (PBH)2026-03-31$595.58M-6.1%
Acadia Pharmaceuticals Inc (ACAD)2025-12-31$982.51M+12.2%
Harmony Biosciences Holdings, Inc. (HRMY)2025-12-31$670.11M+20.1%
Collegium Pharmaceutical, Inc (COLL)2025-12-31$463.26M+22.8%
Emergent BioSolutions Inc. (EBS)2025-12-31$416.70M+15.0%
Pacira BioSciences, Inc. (PCRX)2025-12-31$576.66M+8.7%

Compare ALKS, PAHC, INDV, PBH side by side · Screen every company in Pharmaceutical Preparations ↗